Discovery of pyrido[3,4-g]quinazoline derivatives as CMGC family protein kinase inhibitors: Design, synthesis, inhibitory potency and X-ray co–crystal structure. - Archive ouverte HAL
Article Dans Une Revue European Journal of Medicinal Chemistry Année : 2016

Discovery of pyrido[3,4-g]quinazoline derivatives as CMGC family protein kinase inhibitors: Design, synthesis, inhibitory potency and X-ray co–crystal structure.

Résumé

The design and synthesis of new pyrido[3,4-g]quinazoline derivatives is described as well as their protein kinase inhibitory potencies toward five CMGC family members (CDK5, CK1, GSK3, CLK1 and DYRK1A). The interest for this original tricyclic heteroaromatic scaffold as modulators of CLK1/DYRK1A activity was validated by nanomolar potencies (compounds 12 and 13). CLK1 co–crystal structures with two inhibitors revealed the binding mode of these compounds within the ATP-binding pocket.

Domaines

Chimie
Fichier principal
Vignette du fichier
Knapp-Esvan+et+al+2016.pdf (684.2 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-01308803 , version 1 (15-11-2024)

Identifiants

Citer

Yannick J. Esvan, Wael Zeinyeh, Thibaut Boibessot, Lionel Nauton, Vincent Théry, et al.. Discovery of pyrido[3,4-g]quinazoline derivatives as CMGC family protein kinase inhibitors: Design, synthesis, inhibitory potency and X-ray co–crystal structure.. European Journal of Medicinal Chemistry, 2016, 118, pp.170-177. ⟨10.1016/j.ejmech.2016.04.004⟩. ⟨hal-01308803⟩
103 Consultations
2 Téléchargements

Altmetric

Partager

More